UY26680A1 - TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR. - Google Patents

TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR.

Info

Publication number
UY26680A1
UY26680A1 UY26680A UY26680A UY26680A1 UY 26680 A1 UY26680 A1 UY 26680A1 UY 26680 A UY26680 A UY 26680A UY 26680 A UY26680 A UY 26680A UY 26680 A1 UY26680 A1 UY 26680A1
Authority
UY
Uruguay
Prior art keywords
inhibitor
sodium
type
hydrogen exchanger
nhe
Prior art date
Application number
UY26680A
Other languages
Spanish (es)
Inventor
Weichao George Chen
Eric David Cox
Angel Guzman-Perez
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY26680A1 publication Critical patent/UY26680A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un inhibidor de NHE-1, métodos para utilizar el inhibidor de NHE-1 y composiciones farmacéuticas que contienen el inhibidor de NHE-1. El inhibidor de NHE-1 es útil para la reducción de las lesiones tisulares resultantes de la isquemia de los tejidos.An NHE-1 inhibitor, methods of using the NHE-1 inhibitor, and pharmaceutical compositions containing the NHE-1 inhibitor. The NHE-1 inhibitor is useful for the reduction of tissue damage resulting from tissue ischemia.

UY26680A 2000-04-28 2001-04-24 TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR. UY26680A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
UY26680A1 true UY26680A1 (en) 2001-12-28

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26680A UY26680A1 (en) 2000-04-28 2001-04-24 TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR.

Country Status (40)

Country Link
EP (1) EP1276737A1 (en)
JP (1) JP2003531900A (en)
KR (1) KR20020093079A (en)
CN (1) CN1225466C (en)
AP (1) AP2002002651A0 (en)
AR (1) AR028375A1 (en)
AU (1) AU2001235896A1 (en)
BG (1) BG107139A (en)
BR (1) BR0110268A (en)
CA (1) CA2407535A1 (en)
CO (1) CO5221125A1 (en)
CR (1) CR6797A (en)
CZ (1) CZ20023408A3 (en)
DZ (1) DZ3310A1 (en)
EA (1) EA004882B1 (en)
EE (1) EE200200615A (en)
GT (1) GT200100064A (en)
HN (1) HN2001000042A (en)
HR (1) HRP20020851A2 (en)
HU (1) HUP0300651A2 (en)
IL (1) IL152075A0 (en)
IS (2) IS6567A (en)
MA (1) MA26897A1 (en)
MX (1) MXPA02010600A (en)
MY (1) MY133842A (en)
NO (1) NO20025132L (en)
NZ (1) NZ521348A (en)
OA (1) OA12256A (en)
PA (1) PA8513301A1 (en)
PE (1) PE20011270A1 (en)
PL (1) PL357765A1 (en)
SK (1) SK14872002A3 (en)
SV (1) SV2002000418A (en)
TN (1) TNSN01065A1 (en)
TR (1) TR200202439T2 (en)
UA (1) UA73348C2 (en)
UY (1) UY26680A1 (en)
WO (1) WO2001083470A1 (en)
YU (1) YU79602A (en)
ZA (1) ZA200208605B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436539A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
JP2005511787A (en) * 2001-12-19 2005-04-28 ファイザー・プロダクツ・インク Method for preparing sodium-hydrogen exchange type 1 inhibitor
EP1499317A1 (en) * 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
ES2220185B1 (en) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas NEW INHIBITOR PEPTIDE OF THE NA + / H + EXCHANGER (PINHE), AND ITS APPLICATIONS.
AU2004212957A1 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Novel compounds
RU2518741C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454902A1 (en) * 1998-02-27 2004-09-08 Pfizer Products Inc. N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia

Also Published As

Publication number Publication date
CN1426404A (en) 2003-06-25
ZA200208605B (en) 2003-10-24
NZ521348A (en) 2004-09-24
MXPA02010600A (en) 2003-03-10
PA8513301A1 (en) 2003-09-05
EA200201023A1 (en) 2003-02-27
IL152075A0 (en) 2003-05-29
WO2001083470A1 (en) 2001-11-08
NO20025132L (en) 2002-12-12
EE200200615A (en) 2004-04-15
TNSN01065A1 (en) 2005-11-10
CZ20023408A3 (en) 2004-01-14
UA73348C2 (en) 2005-07-15
NO20025132D0 (en) 2002-10-25
SV2002000418A (en) 2002-07-03
EA004882B1 (en) 2004-08-26
AU2001235896A1 (en) 2001-11-12
IS6567A (en) 2002-09-24
EP1276737A1 (en) 2003-01-22
IS6588A (en) 2002-10-21
HUP0300651A2 (en) 2003-07-28
DZ3310A1 (en) 2001-11-07
CA2407535A1 (en) 2001-11-08
BR0110268A (en) 2003-12-30
BG107139A (en) 2003-07-31
CN1225466C (en) 2005-11-02
HRP20020851A2 (en) 2005-02-28
MA26897A1 (en) 2004-12-20
YU79602A (en) 2006-05-25
SK14872002A3 (en) 2004-03-02
OA12256A (en) 2003-11-06
AP2002002651A0 (en) 2002-12-31
TR200202439T2 (en) 2003-02-21
AR028375A1 (en) 2003-05-07
KR20020093079A (en) 2002-12-12
MY133842A (en) 2007-11-30
HN2001000042A (en) 2001-07-09
PE20011270A1 (en) 2001-12-12
GT200100064A (en) 2002-03-22
CO5221125A1 (en) 2002-11-28
JP2003531900A (en) 2003-10-28
PL357765A1 (en) 2004-07-26
CR6797A (en) 2004-05-17

Similar Documents

Publication Publication Date Title
GT199900022A (en) COMPOUNDS FOR THE TREATMENT OF ISCHEMIA
GT199900150A (en) 1,2,3,4-TETRAHYDROQUINOLINS 2-SUBSTITUTED 4-CARBOXYAMIN SUBSTITUTED.
PA8541601A1 (en) NEW SPIROCICLIC DERIVATIVES AND ITS USE AS INHIBITORS OF PHOSPHODIESTERASA-7.
ES2192213T3 (en) ARILALQUIL-DIAZINONAS AS PHOSPHODIESTERASE IV INHIBITORS.
PA8586801A1 (en) HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
AR018162A1 (en) SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION
UY27203A1 (en) USEFUL BENCIMIDAZOLS IN THE TREATMENT OF SEXUAL DYSFUNCTION
AR030537A1 (en) ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS
UY26680A1 (en) TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR.
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
GT199900113A (en) FKBP INHIBITORS.
ES2182090T3 (en) NEW DERIVATIVES OF PIRROL.
AR006675A1 (en) 4-BENZOILISOTIAZOLES HERBICIDES, PROCEDURE TO OBTAIN THEM, THE HERBICIDES COMPOSITIONS THAT CONTAIN THEM AND THE PROCEDURE OF APPLICATION OF SUCH COMPOUNDS.
ES2175661T3 (en) DERIVATIVES OF ISOFLAVONA, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TR200201167T2 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals.
UY26417A1 (en) TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR CRYSTALS
BR0005122A (en) Method for the preparation of type 1 sodium-hydrogen exchanger inhibitor
DOP2003000569A (en) PHARMACEUTICAL COMPOSITIONS OF ZONIPORIDA MESILATE AND PROCEDURE TO IMPROVE THE SOLUBILITY OF ZONIPORIDA
HN2001000282A (en) ACIDS 3 - OX (ADI) AZOLILPROPANOHYDROXAMICS USEFUL AS INHIBITORS OF PROTEINASE C OF PROCOLAGEN.
AR006676A1 (en) 4-BENZOILISOTIAZOLES HERBICIDES, PROCEDURE TO OBTAIN THEM, THE HERBICIDES COMPOSITIONS THAT CONTAIN THEM AND THE PROCEDURE OF APPLICATION OF THESE COMPOUNDS.
AR013306A1 (en) 4-BENZOILISOTIAZOLES HERBICIDES, PROCEDURE TO OBTAIN THEM, THE HERBICIDES COMPOSITIONS THAT CONTAIN THEM AND THE PROCEDURE OF APPLICATION OF THESE COMPOUNDS.
ECSP003742A (en) TYPE I SODIUM HYDROGEN EXCHANGER CRYSTALS
ES2062940B1 (en) GASTROCINETIC AGENT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
HN2002000058A (en) PCP INHIBITORS OF THE TYPE OF ACIDS 3-HETEROCICLILPROPANOHIDROXAMICOS
DK1119351T3 (en) Use of catechol derivatives as proteinase inhibitors

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130819